Evidence map›Paper›PMID 34755498›Full record

ArticlePhysiological reports2021

A novel evaluation of endothelial dysfunction ex vivo: "Teaching an Old Drug a New Trick".

Lexiao Jin, Daniel J Conklin

Open access · goldAbstract read
In one paragraph

Article in Physiological reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.5field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Lexiao JinAmerican Heart Association-Tobacco Regulation and Addiction Center, University of Louisville, Louisville, Kentucky, USA.
Daniel J ConklinAmerican Heart Association-Tobacco Regulation and Addiction Center, University of Louisville, Louisville, Kentucky, USA.ORCID 0000-0002-8385-9982
American Heart Association · US

Funding

Superfund Training CoreP42ES023716 · NIEHS · UNIVERSITY OF LOUISVILLE · PI HEIN, DAVID W · 2017 to 2025
$18.1M
University of Louisville Center for Integrative Environmental Health SciencesP30ES030283 · NIEHS · UNIVERSITY OF LOUISVILLE · PI Amanda Jo LeBlanc · 2020 to 2026
$10.0M
TBDP30GM127607 · NIGMS · UNIVERSITY OF LOUISVILLE · PI JONES, STEVEN P · 2018 to 2022
$6.3M
Cardiovascular Toxicity of Tobacco Products and ConstituentsR01HL122676 · NHLBI · UNIVERSITY OF LOUISVILLE · PI CONKLIN, DANIEL JOSEPH · 2015 to 2019
$3.7M
Atherogenic Mechanisms of Electronic Nicotine Delivery SystemsR01HL149351 · NHLBI · UNIVERSITY OF LOUISVILLE · PI SRIVASTAVA, SANJAY · 2020 to 2023
$2.9M
Cardiovascular Benefits of Inhaled Biogenic Volatile Organic CompoundsR21ES033323 · NIEHS · UNIVERSITY OF LOUISVILLE · PI CONKLIN, DANIEL JOSEPH · 2021 to 2022
$430k
NHLBI NIH HHS R01 HL122676NHLBI NIH HHS R01 HL149351NIEHS NIH HHS P30 ES030283NIEHS NIH HHS P42 ES023716NIEHS NIH HHS R21 ES033323NIGMS NIH HHS P30 GM127607
6 · The paper itself

Abstract

Cardiovascular disease (CVD) is the leading cause of morbidity and mortality worldwide. Many CVDs begin with endothelium dysfunction (ED), including hypertension, thrombosis, and atherosclerosis. Our assay evaluated ED in isolated murine aorta by quantifying phenylephrine-induced contractions (PE) in the presence of L-NAME, which blocked acetylcholine-induced relaxation (ACh %; >99%). The "L-NAME PE Contraction Ratio" (PECR) was defined as: "PE Tension post-L-NAME" divided by "PE Tension pre-L-NAME." We hypothesized that our novel PE Contraction Ratio would strongly correlate with alterations in endothelium function. Validation 1: PECR and ACh % values of naïve aortas were strongly and positively correlated (PECR vs. ACh %, r

Indexed as

AcetaldehydeAcetylcholineAnimalsAortaEndothelium, VascularEnzyme InhibitorsFemaleFormaldehydeMaleMiceMice, Inbred C57BLNG-Nitroarginine Methyl EsterVasoconstrictionAcetaldehydeAcetylcholineEnzyme InhibitorsFormaldehydeNG-Nitroarginine Methyl Esteraldehydescardiovascular diseaseendotheliumeNOSL-NAME

Identifiers

PMID34755498
PMCPMC8579072
OpenAlexW3214598715

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.